loadpatents
name:-0.027544021606445
name:-0.018572807312012
name:-0.0060849189758301
Kelly; Jeffery W. Patent Filings

Kelly; Jeffery W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kelly; Jeffery W..The latest application filed is for "stabilization of amyloidogenic immunoglobulin light chains".

Company Profile
5.20.29
  • Kelly; Jeffery W. - La Jolla CA
  • Kelly; Jeffery W. - Solana Beach CA
  • Kelly; Jeffery W - LaJolla CA US
  • Kelly; Jeffery W. - LaJolla CA
  • Kelly; Jeffery W. - College Station TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
IRE1 activating compounds for use in therapy
Grant 11,426,402 - Wiseman , et al. August 30, 2
2022-08-30
Stabilization Of Amyloidogenic Immunoglobulin Light Chains
App 20220204485 - Kelly; Jeffery W. ;   et al.
2022-06-30
Sulfur (vi) Fluoride Compounds And Methods For The Preparation Thereof
App 20220000799 - DONG; Jiajia ;   et al.
2022-01-06
Regulators of the Endoplasmic Reticulum Proteostasis Network
App 20210393557 - Cooley; Christina ;   et al.
2021-12-23
Sulfur (VI) fluoride compounds and methods for the preparation thereof
Grant 11,141,385 - Dong , et al. October 12, 2
2021-10-12
Regulators of the endoplasmic reticulum proteostasis network
Grant 11,135,186 - Cooley , et al. October 5, 2
2021-10-05
Ire1 Activating Compounds For Use In Therapy
App 20210008064 - Wiseman; R. Luke ;   et al.
2021-01-14
Sulfur (vi) Fluoride Compounds And Methods For The Preparation Thereof
App 20200397719 - DONG; Jiajia ;   et al.
2020-12-24
Sulfur(VI) fluoride compounds and methods for the preparation thereof
Grant 10,765,645 - Dong , et al. Sep
2020-09-08
Sulfur(vi) Fluoride Compounds And Methods For The Preparation Thereof
App 20190029972 - Dong; Jiajia ;   et al.
2019-01-31
Regulators Of The Endoplasmic Reticulum Proteostasis Network
App 20190008809 - Cooley; Christina ;   et al.
2019-01-10
Sulfur(VI) fluoride compounds and methods for the preparation thereof
Grant 10,117,840 - Dong , et al. November 6, 2
2018-11-06
Transthyretin Antibodies And Uses Thereof
App 20180022797 - JIANG; Xin ;   et al.
2018-01-25
Transthyretin antibodies and uses thereof
Grant 9,790,269 - Jiang , et al. October 17, 2
2017-10-17
Small molecules that covalently modify transthyretin
Grant 9,771,321 - Kelly , et al. September 26, 2
2017-09-26
Sulfur(vi) Fluoride Compounds And Methods For The Preparation Thereof
App 20170196985 - DONG; Jiajia ;   et al.
2017-07-13
Small Molecules That Covalently Modify Transthyretin
App 20170190660 - Kelly; Jeffery W. ;   et al.
2017-07-06
Transthyretin Antibodies And Uses Thereof
App 20160039916 - JIANG; Xin ;   et al.
2016-02-11
Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
Grant 8,906,681 - Kelly , et al. December 9, 2
2014-12-09
Small Molecules That Covalently Modify Transthyretin
App 20140336254 - Kelly; Jeffery W. ;   et al.
2014-11-13
Methods For Treating Transthyretin Amyloid Diseases
App 20140134753 - KELLY; Jeffery W. ;   et al.
2014-05-15
Small molecules that covalently modify transthyretin
Grant 8,703,815 - Kelly , et al. April 22, 2
2014-04-22
Methods for treating transthyretin amyloid diseases
Grant 8,653,119 - Kelly , et al. February 18, 2
2014-02-18
Reliable Stabilization Of N-linked Polypeptide Native States With Enhanced Aromatic Sequons Located In Polypeptide Tight Turns
App 20130034547 - Kelly; Jeffery W. ;   et al.
2013-02-07
Small Molecules That Covalently Modify Transthyretin
App 20120270938 - Kelly; Jeffery W. ;   et al.
2012-10-25
Pharmaceutically acceptable salt of 6-carboxy-2-(3,5 dichlorophenyl)-benzoxazole, and a pharmaceutical composition comprising the salt thereof
Grant 8,168,663 - Kelly , et al. May 1, 2
2012-05-01
Methods For Treating Transthyretin Amyloid Diseases
App 20120065237 - KELLY; Jeffery W. ;   et al.
2012-03-15
Methods For Treating Transthyretin Amyloid Diseases
App 20100120919 - Kelly; Jeffery W. ;   et al.
2010-05-13
Methods for treating transthyretin amyloid diseases
Grant 7,560,488 - Kelly , et al. July 14, 2
2009-07-14
Inhibitors of Transthyretin Amyloid Fibril Formation
App 20090054629 - Kelly; Jeffery W. ;   et al.
2009-02-26
Transthyretin Stabilization
App 20080319175 - Kelly; Jeffery W. ;   et al.
2008-12-25
Inhibitors of transthyretin amyloid fibril formation
Grant 7,312,361 - Kelly , et al. December 25, 2
2007-12-25
Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
Grant 7,214,695 - Kelly , et al. May 8, 2
2007-05-08
Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
Grant 7,214,696 - Kelly , et al. May 8, 2
2007-05-08
Methods for treating transthyretin amyloid diseases
App 20070078186 - Kelly; Jeffery W. ;   et al.
2007-04-05
Genistein inhibition of transthyretin amyloidosis
App 20070037875 - Kelly; Jeffery W. ;   et al.
2007-02-15
Inhibitors of transthyretin amyloid fibril formation
App 20060178527 - Kelly; Jeffery W. ;   et al.
2006-08-10
Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
App 20060057644 - Kelly; Jeffery W. ;   et al.
2006-03-16
Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
App 20050272704 - Kelly, Jeffery W.
2005-12-08
Transthyretin stabilization
App 20050261365 - Kelly, Jeffery W. ;   et al.
2005-11-24
Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
App 20040152140 - Kelly, Jeffery W. ;   et al.
2004-08-05
.beta.-sheet nucleating peptidomimetics
Grant 6,034,211 - Kelly March 7, 2
2000-03-07
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed